Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 24, 2017
Pharmacy Choice - News - Drug Delivery Systems - May 24, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 70     Next >>     Go To Page:

5/24/17 - Data on Transdermal Delivery Reported by Researchers at University of California (Deformable Nanovesicles Synthesized through an Adaptable...
Data on Transdermal Delivery Reported by Researchers at University of California. Financial supporters for this research include Mary S. Easton Center for Alzheimer s Disease Research, National Institutes of Health. The news reporters obtained a quote from the research from the University of California, "To determine the ability of DNV-encapsula
5/24/17 - Injectable Drug Delivery Market to Grow at CAGR Of 13.9% According to Forecast from 2017 to 2022
Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter International, Inc., Becton, Dickinson and Company. Asia Pacific is expected to be the fastest growing market on account of its emerging healthcare sector. Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter Internatio
5/24/17 - Investigators from University of Tehran Have Reported New Data on Transdermal Delivery (Microfluidic-aided fabrication of nanoparticles blend based...
According to news originating from Tehran, Iran, by NewsRx correspondents, research stated, "The aim of this work was to provide a microfluidic-aided fabrication of nanoparticles based on chitosan/poly/ cellulose laurate[ CS/P (NIPAAm-co-AAc/CL] blend for transdermal multidrug delivery applications. For more information on this research see:...
5/24/17 - Recent Findings from S.G. Chen and Co-Authors Provide New Insights into Colloids and Interface Science (Facile fabrication of polyurethane...
According to news reporting out of Shenzhen, People's Republic of China, by NewsRx editors, research stated, "A tailor-made traceable pH-sensitive drug delivery system based on polyurethane microcapsules was fabricated using a facile double-emulsion method containing 3,3'- dioctadecyloxacarbocyanine per chlorate, doxorubicin and sodium bicarbonate.
5/24/17 - Reports Outline Transdermal Delivery Study Findings from Yonsei University (Enhanced Transdermal Delivery by Combined Application of Dissolving...
Reports Outline Transdermal Delivery Study Findings from Yonsei University. According to news reporting from Seoul, South Korea, by NewsRx journalists, research stated, "Dissolving microneedle, a transdermal drug delivery system in which drugs are encapsulated in a biodegradable polymeric microstructure, is designed to dissolve after skin penetrati
5/24/17 - Studies from Southern Medical University Yield New Data on Transdermal Delivery (Mechanism of transdermal permeation promotion of lipophilic drugs by...
By a News Reporter-Staff News Editor at Biotech Week Research findings on Drugs and Therapies- Transdermal Delivery are discussed in a new report. According to news reporting originating from Guangdong, People's Republic of China, by NewsRx correspondents, research stated, "Ethosomes can promote the penetration of lipophilic drugs into the skin,
5/24/17 - Studies in the Area of Alzheimer Disease Reported from Tarbiat Modares University (Preparation and Characterization of Rivastigmine Transdermal Patch...
Studies in the Area of Alzheimer Disease Reported from Tarbiat Modares University. According to news reporting from Tehran, Iran, by NewsRx journalists, research stated, "Here we report a novel approach for preparation of a 6- day transdermal drug delivery system as treatment for mild to moderate Alzheimer's disease. The news correspondents obtaine
5/23/17 - 7th American DDF Summit: Drug Delivery & Formulation - Boston, United States - August 28-29, 2017
Dublin- Research and Markets has announced the addition of the "7th American DDF Summit" conference to their offering. The growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mindset from discovery right through to production. Having built a following and an audience on the West Coast, the summit is now mov
5/23/17 - 7th American DDF Summit: Drug Delivery & Formulation - Boston, United States - August 28-29, 2017 - Research and Markets
Research and Markets has announced the addition of the "7th American DDF Summit" conference to their offering. The growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mindset from discovery right through to production. Having built a following and an audience on the West Coast, the summit is now moving acro
5/23/17 - Aptar Pharma to Highlight Drug Delivery Systems Portfolio at FCE Brazil
With almost 17,000 visitors, FCE is the key tradeshow focused on the pharmaceutical and cosmetics markets in Latin America, and is an annual networking place for all the major players in the pharmaceutical industry. Aptar Pharma has a strong presence in Latin America, with several offices in Brazil and Argentina, and a fully-dedicated manufacturing
5/23/17 - Global Injectable Drug Delivery Market (2017-2022) - Grow Pricing, Features, Reviews & Comparison of Alternatives
Global Market Research Report on Injectable Drug Delivery Market 2016 is a professional and in-depth complete study on the current state of the Injectable Drug Delivery worldwide.Deerfield Beach, FL 05/23/2017 New report on Injectable Drug Delivery systems are well known and highly accepted due to their faster onset of action with high effica
5/23/17 - Horizon Pharma plc Announces Agreement to Sell European Marketing Rights to PROCYSBI (cysteamine bitartrate) delayed-release capsules and QUINSAIR? (levofloxacin inhalation solution) in Europe, Middle East and Africa (EMEA) Regions to Chiesi Farm
Horizon Pharma plc, a biopharmaceutical company focused on improving patients lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has reached an agreement to sell a European subsidiary that owns the marketing rights to PROCYSBI ...
5/23/17 - Medical Plastics Market Report Predicts Healthy Growth by 2022 - Scalar Market Research
New Research& Forecast Report on Medical Plastics Market by 2022 Chicago, IL 05/23/2017 According to the new market research report, " Medical Plastics Market, by Types, Applications- Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global medical plastics market is set to witness gro
5/23/17 - New Drug Delivery Systems Findings Reported from Hangzhou Dianzi University (Molecular dynamics study on DNA nanotubes as drug delivery vehicle for...
New Drug Delivery Systems Findings Reported from Hangzhou Dianzi University. According to news originating from Hangzhou, People's Republic of China, by NewsRx correspondents, research stated, "In recent years, self-assembled DNA nanotubes have emerged as a type of nano-biomaterials with great potential for biomedical applications.
5/23/17 - Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS
DUBLIN and HERTFORDSHIRE, United Kingdom and PITTSBURGH, May 23, 2017/ PRNewswire/ Theravance Biopharma, Inc. and Mylan N.V. today announced the presentation of additional efficacy and safety data from the three-month, pivotal Phase 3 studies of revefenacin at the American Thoracic Society International Conference in Washington, D.C.
5/23/17 - Zydus receives final approval for antihistamine drug [India Infoline News Service]
Pharma giant Zydus Cadila has received final approval from the US Food& Drug Administration to market Cyproheptadine Hydrochloride tablets. Pharma giant Zydus Cadila has received final approval from the US Food& Drug Administration to market Cyproheptadine Hydrochloride tablets USP, 4 mg. Cadila Healthcare stock started its Tuesday s intraday tr
5/22/17 - Adamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in Epilepsy
Adamas Pharmaceuticals, Inc. today announced a presentation of positive data from the Phase 1 a clinical trial of ADS-4101 modified-release capsules, in a podium presentation at the 14 th Antiepileptic Drug and Device Trials Conference. We have successfully confirmed our hypothesis that the rapid initial rise in blood levels contributes to the
5/22/17 - Biomaterials Market in Brazil Will Reach USD 5.18 billion in 2022: Zion Market Research
Zion Market Research has published a new report titled Biomaterials Market by Materials for Drug Delivery, Dental Products, Surgical Appliances& Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 2022. According to the report, demand for Brazi
5/22/17 - Data on Superinfection Discussed by Researchers at Peking University People's Hospital (Pharmacokinetic and Pharmacodynamic Efficacies of Continuous...
Data on Superinfection Discussed by Researchers at Peking University People's Hospital. By a News Reporter-Staff News Editor at Clinical Trials Week Current study results on Immune System Diseases and Conditions- Superinfection have been published. The news correspondents obtained a quote from the research from Peking University People's Hospital
5/22/17 - Elite Pharmaceuticals Acquires Trimipramine ANDA
Elite Pharmaceuticals, Inc., today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application for Trimipramine Maleate Capsules 25, 50 and 100 mg, from Mikah Pharma, LLC. Reddy s Laboratories, Inc.,, will market and sell the Trimipramine products. Elite Pharmaceuticals, Inc. is a specialty pharmaceutical c
5/22/17 - EMED Partners with Global Pharma Leaders in New FDA 510(k) Clearance
EMED Technologies Corporation is pleased to announce the SCIg60 Infusion System has been granted expanded indications as the only Immune Globulin Subcutaneous mechanical pump infusion system cleared by the U.S. FDA. The FDA 510 issuance letter can be found at: https://www.accessdata.fda.gov/cdrh-docs/pdf16/K161906. pdf. In this most recent FDA...
5/22/17 - FDA Approves Genentech's Actemra (Tocilizumab) for Giant Cell Arteritis
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved Actemra subcutaneous injection for the treatment of GCA, a chronic and severe autoimmune condition. Actemra is the first therapy approved by the FDA for the treatment of adult patients with GCA. Today s FDA decision means people
5/22/17 - Global Drug Delivery Devices Market 2017: Manufacturers, Regions, Type and Application
Global Market Research Report on Drug Delivery Devices Market 2017 is a professional and in-depth complete study on the current state of the Drug Delivery Devices worldwide.Deerfield Beach, FL 05/22/2017 Latest industry research report on: Global Drug Delivery Devices Market 2016: Industry Research, Size, Shares, Key Trends, Demand, Analysis,
5/22/17 - Global Drug Delivery Technology Market 2017 Size, Development Status, Type and Application,Segmentation,Forecast by 2022
PUNE, INDIA, May 22, 2017/ EINPresswire.com/ Drug Delivery Technology Market: Executive Summary This report studies the global Drug Delivery Technology market, analyzes and researches the Drug Delivery Technology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in
5/22/17 - InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery
By a News Reporter-Staff News Editor at Pharma Business Week InMed Pharmaceuticals, Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced the filing of a provisional patent application in the United States for INM-085 as a cannabinoid-based topical therapy for glaucoma
Articles(s): 1 - 25 of 70     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415